Howard R. Mellor - Concepedia

Author

Howard R. Mellor

Also Known As

H MELLOR, H Mellor, H R Mellor, H. MELLOR, H. R. Mellor, H.R. Mellor, Howard Mellor, Howard R. MELLOR, Howard R. Mellor, Howard R. MELLOR

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Oxford John Radcliffe Hospital The University of Sydney AstraZeneca (United Kingdom)Cancer Research UK

About

Howard R. Mellor is an author at University of Oxford specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.3K
2	Engineering	3	3	100
3	Natural Sciences	2	2	68
4	Health Sciences	1	1	28
5	Public Health	1	1	57

Howard R. Mellor

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Regulation of autophagy by ATF4 in response to severe hypoxia Tomasz Rzymski, Massimo Milani, Luke Pike, Oncogene InflammationCell AutophagyMitophagyRedox RegulatorPhysiology	2010	364
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib Manuela Milani, Tomasz Rzymski, Howard R. Mellor, Cancer Research Breast OncologyCell DeathAtf4 StabilizationEndoplasmic Reticulum StressCancer Biology	2009	291
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors Mark J. Anderton, Howard R. Mellor, Alex Bell, Toxicologic Pathology Human GrowthPathologyPharmacotherapyCongenital Heart AnomalyCardiovascular Toxicity	2011	280
A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs Howard R. Mellor, David Ferguson, Richard Callaghan British Journal of Cancer	2005	115
Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins Howard R. Mellor, James P. Nolan, Lea Pickering, Biochemical Journal	2002	75
Elemental Tomography of Cancer-Cell Spheroids Reveals Incomplete Uptake of Both Platinum(II) and Platinum(IV) Complexes Rebecca A. Alderden, Howard R. Mellor, Szabolcs Modok, Journal of the American Chemical Society EngineeringOncologic ImagingX-ray Fluorescence MicrotomographyTumor BiologyTherapeutic Imaging	2007	57
An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, Toxicological Sciences Cardiac MuscleHeart FailurePathologyCardiovascular ToxicityRat Model	2014	57
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation Howard R. Mellor, Frances M. Platt, Raymond A. Dwek, Biochemical Journal Protein GlycosylationMedicinal ChemistryMembrane DisruptionProteinlipid InteractionBiochemistry	2003	54
Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug Rebecca A. Alderden, Howard R. Mellor, Szabolcs Modok, Biochemical Pharmacology OncologyMedicinePlatinum Anticancer DrugPharmacotherapyAnti-cancer Agent	2006	53
The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes Howard R. Mellor, Sarah Snelling, Matthew D. Hall, Biochemical Pharmacology Novel PlatinumMedicineTumour Microenvironmental FactorsTumor TargetingAnti-cancer Agent	2005	50

Page 1